EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity

Pinhua Wang, Sunayana Sarkar, Menghuan Zhang, Tingting Xiao, Fenhua Kong, Zhe Zhang, Deepa Balasubramanian, Nandan Jayaram, Sayantan Datta, Ruyu He, Ping Wu, Peng Chao und 6 weitere

eLife · 2024

DOI: 10.7554/elife.88318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Pinhua Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunmi…. Hauptthemen laut MEDLINE: Dyrk Kinases, Mechanistic Target of Rapamycin Complex 1, Protein Serine-Threonine Kinases, Protein-Tyrosine Kinases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Department of Biotechnology, Ministry of Science & Technology, India, Wellcome Trust/DBT India Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DYRK1A, a ubiquitously expressed kinase , is linked to the dominant intellectual developmental disorder, microcephaly, and Down syndrome in humans. It regulates numerous cellular processes such as cell cycle, vesicle trafficking, and microtubule assembly. DYRK1A is a critical regulator of organ growth; however, how it regulates organ growth is not fully understood. Here, we show that the knockdown of DYRK1A in mammalian cells results in reduced cell size, which depends on mTORC1. Using proteomic approaches, we found that DYRK1A interacts with the tuberous sclerosis complex (TSC) proteins, namely TSC1 and TSC2, which negatively regulate mTORC1 activation. Furthermore, we show that DYRK1A phosphorylates TSC2 at T1462, a modification known to inhibit TSC activity and promote mTORC1 activity. We also found that the reduced cell growth upon knockdown of DYRK1A can be rescued by overexpression of RHEB, an activator of mTORC1. Our findings suggest that DYRK1A inhibits TSC complex activity through inhibitory phosphorylation on TSC2, thereby promoting mTORC1 activity. Furthermore, using the Drosophila neuromuscular junction as a model, we show that the mnb, the fly homologs of DYRK1A , is rescued by RHEB overexpression, suggesting a conserved role of DYRK1A in TORC1 regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dyrk KinasesMechanistic Target of Rapamycin Complex 1Protein Serine-Threonine KinasesProtein-Tyrosine KinasesTuberous Sclerosis Complex 2 ProteinAnimalsHumansCell SizeDrosophilaDrosophila ProteinsGene Knockdown TechniquesHEK293 CellsMultiprotein ComplexesPhosphorylationProtein BindingProteomicsTuberous Sclerosis Complex 1 ProteinTumor Suppressor Proteins

Stichwörter der Autor:innen

D. melanogasterDYRK1ADrosophila melanogasterbiochemistrycell biologycell growthchemical biologymicrocephaly

Substanzen

Drosophila ProteinsDyrk KinasesDYRK1A protein, humanMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesTSC1 protein, humanTSC2 protein, humanTuberous Sclerosis Complex 1 Protein

Autor:innen und Institutionen

  • State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China.
  • Tata Institute of Fundamental Research, Hyderabad, India.
  • CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.
  • National Facility for Protein Science in Shanghai, Zhangjiang Lab, Shanghai, China.
  • Stowers Institute for Medical Research, Kansas City, United States.

ORCID-Profile: Michael Washburn, Laurence A Florens, Sonal Nagarkar-Jaiswal, Manish Jaiswal, Man Mohan

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India
  • Department of Biotechnology, Ministry of Science & Technology, India
  • Wellcome Trust/DBT India Alliance
  • NIH HHS
  • Wellcome Trust
  • National Natural Science Foundation of China
  • Department of Atomic Energy, Government of India
  • Stowers Institute for Medical Research

Zitieren

APA

Wang, P., Sarkar, S., Zhang, M., Xiao, T., Kong, F., Zhang, Z., Balasubramanian, D., Jayaram, N., Datta, S., He, R., Wu, P., Chao, P., Zhang, Y., Washburn, M., Florens, L. A., Nagarkar-Jaiswal, S., Jaiswal, M., & Mohan, M. (2024). DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity. eLife. https://doi.org/10.7554/elife.88318

Vancouver

Wang P, Sarkar S, Zhang M, Xiao T, Kong F, Zhang Z, et al. DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity. eLife. 2024. doi:10.7554/elife.88318

BibTeX
@article{Wang2024,
  author = {Wang, Pinhua and Sarkar, Sunayana and Zhang, Menghuan and Xiao, Tingting and Kong, Fenhua and Zhang, Zhe and Balasubramanian, Deepa and Jayaram, Nandan and Datta, Sayantan and He, Ruyu and Wu, Ping and Chao, Peng and Zhang, Ying and Washburn, Michael and Florens, Laurence A and Nagarkar-Jaiswal, Sonal and Jaiswal, Manish and Mohan, Man},
  title = {DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity},
  journal = {eLife},
  year = {2024},
  doi = {10.7554/elife.88318}
}
Kostenlos starten →